We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Seroconversion Panels Improve Diagnostic Testing/Drug Discovery Opportunities

By Labmedica staff writers
Posted on 07 May 2008
Seroconversion panels for human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) remain stable for a minimum of 25 years. More...
This extended shelf life allows in vitro diagnostic (IVD) companies to benchmark improvements in assay development for HIV, HBV, and HCV.

Seroconversion panels are plasma specimens collected from a single donor during the development of viral infection and the subsequent immune response. Panels for HIV, HBV, and HCV that had been collected as early as 1981 and as recently as 1996 were evaluated by comparing the earliest test results available to test results generated from the same plasma in 2007. Antibodies to HIV, HCV, and hepatitis B-surface antigen (HBsAg) were tested. Results demonstrated that these viral markers show no deterioration over a period of greater than 20 years even when stored in suboptimal conditions.

SeraCare Life Sciences (Milford, MA, USA) presented the data demonstrating the stability of its Seroconversion panels at the 24th annual Clinical Virology Symposium in April 2008, in Daytona Beach, FL (USA).

SeraCare provides vital products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics. The company's range of products includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking, and contract research services.


Related Links:
SeraCare Life Sciences

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.